Seed, Pre-Seed
$1.5M – $10.0M
$68M
16+ companies
5 partners
Investment Thesis
Astellas Venture Management invests in early-stage therapeutic innovation, focusing on biopharma and AI-based drug design.
Meet the Team
Industry Focus
Invests In
Portfolio Companies (16)
Other
Atomwise
Vector BioPharma
DeepSeq.AI
"Discovered via firm_website (high confidence)"
Serna Bio
"Discovered via firm_website (high confidence)"
Solu Therapeutics
"Discovered via firm_website (high confidence)"
Develops therapeutics targeting soluble targets in immunology and inflammation.
PhoreMost
"Discovered via perplexity (medium confidence)"
UK-based developer of small molecule neoantigen immuno-oncology therapies.
Somite Therapeutics
"Discovered via perplexity (medium confidence)"
Builds cellular therapies for muscle diseases using stem cell tech.
Turn Biotechnologies
"Discovered via perplexity (medium confidence)"
Develops mRNA-based therapies for cellular rejuvenation in age-related diseases.
CoMentis
"Discovered via perplexity (medium confidence)"
Focuses on neurodegenerative disease therapies targeting protein misfolding.
Avilar Therapeutics
"Discovered via perplexity (medium confidence)"
Engineers protein degradation platforms for autoimmune and inflammatory diseases.
Browse More Investors
Frequently Asked Questions
See if Astellas Venture Management is a match for your startup
Upload your pitch deck to see how well you match with Astellas Venture Management and 200+ other VC firms.